nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—ALB—multiple sclerosis	0.47	1	CbGaD
Magnesium salicylate—PTGS2—Triamcinolone—multiple sclerosis	0.141	0.321	CbGbCtD
Magnesium salicylate—PTGS2—Betamethasone—multiple sclerosis	0.121	0.275	CbGbCtD
Magnesium salicylate—ALB—Prednisone—multiple sclerosis	0.0708	0.162	CbGbCtD
Magnesium salicylate—PTGS2—Dexamethasone—multiple sclerosis	0.0701	0.16	CbGbCtD
Magnesium salicylate—ALB—Methotrexate—multiple sclerosis	0.0355	0.0812	CbGbCtD
Magnesium salicylate—Olsalazine—IFNG—multiple sclerosis	0.00288	0.787	CrCbGaD
Magnesium salicylate—Localized exfoliation—Triamcinolone—multiple sclerosis	0.00257	0.0319	CcSEcCtD
Magnesium salicylate—Epigastric pain—Mitoxantrone—multiple sclerosis	0.0019	0.0236	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Cladribine—multiple sclerosis	0.00135	0.0167	CcSEcCtD
Magnesium salicylate—Ecchymosis—Cladribine—multiple sclerosis	0.00126	0.0157	CcSEcCtD
Magnesium salicylate—Lethargy—Cladribine—multiple sclerosis	0.00103	0.0128	CcSEcCtD
Magnesium salicylate—Hypocalcaemia—Mitoxantrone—multiple sclerosis	0.001	0.0124	CcSEcCtD
Magnesium salicylate—Stinging—Prednisolone—multiple sclerosis	0.000928	0.0115	CcSEcCtD
Magnesium salicylate—PTGS2—Fluocinonide—Methylprednisolone—multiple sclerosis	0.000872	0.159	CbGdCrCtD
Magnesium salicylate—PTGS2—Fluocinonide—Dexamethasone—multiple sclerosis	0.000858	0.156	CbGdCrCtD
Magnesium salicylate—PTGS2—Fluocinonide—Betamethasone—multiple sclerosis	0.000858	0.156	CbGdCrCtD
Magnesium salicylate—Stinging—Triamcinolone—multiple sclerosis	0.000853	0.0106	CcSEcCtD
Magnesium salicylate—PTGS2—Fluocinonide—Triamcinolone—multiple sclerosis	0.000839	0.153	CbGdCrCtD
Magnesium salicylate—Abdominal discomfort—Cladribine—multiple sclerosis	0.000838	0.0104	CcSEcCtD
Magnesium salicylate—Ecchymosis—Mitoxantrone—multiple sclerosis	0.000828	0.0103	CcSEcCtD
Magnesium salicylate—Hypotension—Fingolimod—multiple sclerosis	0.00082	0.0102	CcSEcCtD
Magnesium salicylate—Stinging—Betamethasone—multiple sclerosis	0.000774	0.00962	CcSEcCtD
Magnesium salicylate—Stinging—Dexamethasone—multiple sclerosis	0.000774	0.00962	CcSEcCtD
Magnesium salicylate—Epistaxis—Cladribine—multiple sclerosis	0.000736	0.00914	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Azathioprine—multiple sclerosis	0.000682	0.00847	CcSEcCtD
Magnesium salicylate—Ecchymosis—Prednisolone—multiple sclerosis	0.00068	0.00845	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Cladribine—multiple sclerosis	0.000662	0.00822	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Triamcinolone—multiple sclerosis	0.00066	0.0082	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000659	0.00818	CcSEcCtD
Magnesium salicylate—Burning sensation—Methotrexate—multiple sclerosis	0.000657	0.00817	CcSEcCtD
Magnesium salicylate—Oesophagitis—Methylprednisolone—multiple sclerosis	0.00063	0.00783	CcSEcCtD
Magnesium salicylate—Ecchymosis—Triamcinolone—multiple sclerosis	0.000625	0.00777	CcSEcCtD
Magnesium salicylate—Ecchymosis—Methylprednisolone—multiple sclerosis	0.000624	0.00775	CcSEcCtD
Magnesium salicylate—Pruritus—Fingolimod—multiple sclerosis	0.000621	0.00771	CcSEcCtD
Magnesium salicylate—Stupor—Methotrexate—multiple sclerosis	0.000611	0.0076	CcSEcCtD
Magnesium salicylate—Erythema—Cladribine—multiple sclerosis	0.000609	0.00757	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Mitoxantrone—multiple sclerosis	0.000608	0.00755	CcSEcCtD
Magnesium salicylate—Diarrhoea—Fingolimod—multiple sclerosis	0.0006	0.00746	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Dexamethasone—multiple sclerosis	0.000599	0.00744	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Betamethasone—multiple sclerosis	0.000599	0.00744	CcSEcCtD
Magnesium salicylate—Dizziness—Fingolimod—multiple sclerosis	0.00058	0.00721	CcSEcCtD
Magnesium salicylate—Oesophagitis—Dexamethasone—multiple sclerosis	0.000573	0.00712	CcSEcCtD
Magnesium salicylate—Oesophagitis—Betamethasone—multiple sclerosis	0.000573	0.00712	CcSEcCtD
Magnesium salicylate—Ecchymosis—Betamethasone—multiple sclerosis	0.000567	0.00705	CcSEcCtD
Magnesium salicylate—Ecchymosis—Dexamethasone—multiple sclerosis	0.000567	0.00705	CcSEcCtD
Magnesium salicylate—Headache—Fingolimod—multiple sclerosis	0.00055	0.00683	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Azathioprine—multiple sclerosis	0.000538	0.00669	CcSEcCtD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.000526	0.0958	CbGdCrCtD
Magnesium salicylate—Weight increased—Mitoxantrone—multiple sclerosis	0.000523	0.0065	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Prednisone—multiple sclerosis	0.000522	0.00648	CcSEcCtD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.000518	0.0943	CbGdCrCtD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.000518	0.0943	CbGdCrCtD
Magnesium salicylate—Drowsiness—Mitoxantrone—multiple sclerosis	0.000513	0.00637	CcSEcCtD
Magnesium salicylate—PTGS2—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.000506	0.0921	CbGdCrCtD
Magnesium salicylate—Confusional state—Cladribine—multiple sclerosis	0.000501	0.00623	CcSEcCtD
Magnesium salicylate—Oesophagitis—Prednisone—multiple sclerosis	0.000499	0.0062	CcSEcCtD
Magnesium salicylate—Oedema—Cladribine—multiple sclerosis	0.000497	0.00618	CcSEcCtD
Magnesium salicylate—Ecchymosis—Prednisone—multiple sclerosis	0.000494	0.00614	CcSEcCtD
Magnesium salicylate—Sweating—Mitoxantrone—multiple sclerosis	0.000491	0.00611	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Cladribine—multiple sclerosis	0.000481	0.00597	CcSEcCtD
Magnesium salicylate—Anorexia—Cladribine—multiple sclerosis	0.000474	0.00589	CcSEcCtD
Magnesium salicylate—Hypotension—Cladribine—multiple sclerosis	0.000465	0.00577	CcSEcCtD
Magnesium salicylate—Lethargy—Betamethasone—multiple sclerosis	0.000465	0.00577	CcSEcCtD
Magnesium salicylate—Lethargy—Dexamethasone—multiple sclerosis	0.000465	0.00577	CcSEcCtD
Magnesium salicylate—Hepatitis—Mitoxantrone—multiple sclerosis	0.00046	0.00572	CcSEcCtD
Magnesium salicylate—Somnolence—Cladribine—multiple sclerosis	0.000442	0.00549	CcSEcCtD
Magnesium salicylate—Depressed level of consciousness—Methotrexate—multiple sclerosis	0.000441	0.00548	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Methotrexate—multiple sclerosis	0.000436	0.00542	CcSEcCtD
Magnesium salicylate—Asthma—Triamcinolone—multiple sclerosis	0.000434	0.00539	CcSEcCtD
Magnesium salicylate—Decreased appetite—Cladribine—multiple sclerosis	0.000432	0.00537	CcSEcCtD
Magnesium salicylate—Weight increased—Prednisolone—multiple sclerosis	0.000429	0.00533	CcSEcCtD
Magnesium salicylate—Pain—Cladribine—multiple sclerosis	0.000425	0.00528	CcSEcCtD
Magnesium salicylate—Constipation—Cladribine—multiple sclerosis	0.000425	0.00528	CcSEcCtD
Magnesium salicylate—Ecchymosis—Methotrexate—multiple sclerosis	0.000413	0.00513	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Cladribine—multiple sclerosis	0.00041	0.00509	CcSEcCtD
Magnesium salicylate—Lethargy—Prednisone—multiple sclerosis	0.000405	0.00503	CcSEcCtD
Magnesium salicylate—Erythema—Mitoxantrone—multiple sclerosis	0.000401	0.00498	CcSEcCtD
Magnesium salicylate—Urticaria—Cladribine—multiple sclerosis	0.000395	0.00491	CcSEcCtD
Magnesium salicylate—Weight increased—Triamcinolone—multiple sclerosis	0.000395	0.0049	CcSEcCtD
Magnesium salicylate—Weight increased—Methylprednisolone—multiple sclerosis	0.000394	0.00489	CcSEcCtD
Magnesium salicylate—Dysgeusia—Mitoxantrone—multiple sclerosis	0.000392	0.00487	CcSEcCtD
Magnesium salicylate—Hypotension—Azathioprine—multiple sclerosis	0.000378	0.0047	CcSEcCtD
Magnesium salicylate—Sweating—Methylprednisolone—multiple sclerosis	0.00037	0.0046	CcSEcCtD
Magnesium salicylate—Epistaxis—Triamcinolone—multiple sclerosis	0.000365	0.00453	CcSEcCtD
Magnesium salicylate—Weight increased—Betamethasone—multiple sclerosis	0.000358	0.00445	CcSEcCtD
Magnesium salicylate—Weight increased—Dexamethasone—multiple sclerosis	0.000358	0.00445	CcSEcCtD
Magnesium salicylate—Pruritus—Cladribine—multiple sclerosis	0.000352	0.00437	CcSEcCtD
Magnesium salicylate—Hallucination—Methylprednisolone—multiple sclerosis	0.000345	0.00428	CcSEcCtD
Magnesium salicylate—Diarrhoea—Cladribine—multiple sclerosis	0.00034	0.00423	CcSEcCtD
Magnesium salicylate—Lethargy—Methotrexate—multiple sclerosis	0.000338	0.0042	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Azathioprine—multiple sclerosis	0.000333	0.00414	CcSEcCtD
Magnesium salicylate—Confusional state—Mitoxantrone—multiple sclerosis	0.00033	0.0041	CcSEcCtD
Magnesium salicylate—Dizziness—Cladribine—multiple sclerosis	0.000329	0.00409	CcSEcCtD
Magnesium salicylate—Erythema—Prednisolone—multiple sclerosis	0.000329	0.00408	CcSEcCtD
Magnesium salicylate—Oedema—Mitoxantrone—multiple sclerosis	0.000327	0.00406	CcSEcCtD
Magnesium salicylate—Shock—Mitoxantrone—multiple sclerosis	0.000322	0.004	CcSEcCtD
Magnesium salicylate—Vomiting—Cladribine—multiple sclerosis	0.000316	0.00393	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.000316	0.00393	CcSEcCtD
Magnesium salicylate—Rash—Cladribine—multiple sclerosis	0.000314	0.0039	CcSEcCtD
Magnesium salicylate—Hallucination—Dexamethasone—multiple sclerosis	0.000313	0.00389	CcSEcCtD
Magnesium salicylate—Hallucination—Betamethasone—multiple sclerosis	0.000313	0.00389	CcSEcCtD
Magnesium salicylate—Dermatitis—Cladribine—multiple sclerosis	0.000313	0.00389	CcSEcCtD
Magnesium salicylate—Weight increased—Prednisone—multiple sclerosis	0.000312	0.00388	CcSEcCtD
Magnesium salicylate—Anorexia—Mitoxantrone—multiple sclerosis	0.000312	0.00387	CcSEcCtD
Magnesium salicylate—Headache—Cladribine—multiple sclerosis	0.000312	0.00387	CcSEcCtD
Magnesium salicylate—Hypotension—Mitoxantrone—multiple sclerosis	0.000305	0.0038	CcSEcCtD
Magnesium salicylate—Erythema—Triamcinolone—multiple sclerosis	0.000302	0.00376	CcSEcCtD
Magnesium salicylate—Erythema—Methylprednisolone—multiple sclerosis	0.000302	0.00375	CcSEcCtD
Magnesium salicylate—Oxcarbazepine—ALB—multiple sclerosis	0.000301	0.0822	CrCbGaD
Magnesium salicylate—Dysgeusia—Triamcinolone—multiple sclerosis	0.000296	0.00368	CcSEcCtD
Magnesium salicylate—Nausea—Cladribine—multiple sclerosis	0.000295	0.00367	CcSEcCtD
Magnesium salicylate—Somnolence—Mitoxantrone—multiple sclerosis	0.000291	0.00361	CcSEcCtD
Magnesium salicylate—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000288	0.00358	CcSEcCtD
Magnesium salicylate—Asthma—Methotrexate—multiple sclerosis	0.000286	0.00356	CcSEcCtD
Magnesium salicylate—Decreased appetite—Mitoxantrone—multiple sclerosis	0.000284	0.00353	CcSEcCtD
Magnesium salicylate—Pain—Mitoxantrone—multiple sclerosis	0.00028	0.00347	CcSEcCtD
Magnesium salicylate—Constipation—Mitoxantrone—multiple sclerosis	0.00028	0.00347	CcSEcCtD
Magnesium salicylate—Diarrhoea—Azathioprine—multiple sclerosis	0.000277	0.00344	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000275	0.00341	CcSEcCtD
Magnesium salicylate—Erythema—Betamethasone—multiple sclerosis	0.000274	0.00341	CcSEcCtD
Magnesium salicylate—Erythema—Dexamethasone—multiple sclerosis	0.000274	0.00341	CcSEcCtD
Magnesium salicylate—Hallucination—Prednisone—multiple sclerosis	0.000273	0.00339	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000269	0.00335	CcSEcCtD
Magnesium salicylate—Oedema—Prednisolone—multiple sclerosis	0.000268	0.00333	CcSEcCtD
Magnesium salicylate—Dizziness—Azathioprine—multiple sclerosis	0.000267	0.00332	CcSEcCtD
Magnesium salicylate—Salicylic acid—ALB—multiple sclerosis	0.000267	0.0729	CrCbGaD
Magnesium salicylate—Shock—Prednisolone—multiple sclerosis	0.000264	0.00328	CcSEcCtD
Magnesium salicylate—Urticaria—Mitoxantrone—multiple sclerosis	0.00026	0.00323	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000259	0.00322	CcSEcCtD
Magnesium salicylate—Vomiting—Azathioprine—multiple sclerosis	0.000257	0.00319	CcSEcCtD
Magnesium salicylate—Drowsiness—Methotrexate—multiple sclerosis	0.000255	0.00317	CcSEcCtD
Magnesium salicylate—Rash—Azathioprine—multiple sclerosis	0.000255	0.00317	CcSEcCtD
Magnesium salicylate—Dermatitis—Azathioprine—multiple sclerosis	0.000255	0.00317	CcSEcCtD
Magnesium salicylate—Flushing—Prednisone—multiple sclerosis	0.000255	0.00316	CcSEcCtD
Magnesium salicylate—Headache—Azathioprine—multiple sclerosis	0.000253	0.00315	CcSEcCtD
Magnesium salicylate—Confusional state—Methylprednisolone—multiple sclerosis	0.000248	0.00308	CcSEcCtD
Magnesium salicylate—Oedema—Triamcinolone—multiple sclerosis	0.000247	0.00306	CcSEcCtD
Magnesium salicylate—Sweating—Methotrexate—multiple sclerosis	0.000245	0.00304	CcSEcCtD
Magnesium salicylate—Shock—Triamcinolone—multiple sclerosis	0.000243	0.00302	CcSEcCtD
Magnesium salicylate—Shock—Methylprednisolone—multiple sclerosis	0.000242	0.00301	CcSEcCtD
Magnesium salicylate—Epistaxis—Methotrexate—multiple sclerosis	0.000241	0.00299	CcSEcCtD
Magnesium salicylate—Nausea—Azathioprine—multiple sclerosis	0.00024	0.00298	CcSEcCtD
Magnesium salicylate—Erythema—Prednisone—multiple sclerosis	0.000239	0.00297	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000238	0.00296	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000238	0.00296	CcSEcCtD
Magnesium salicylate—Hypotension—Methylprednisolone—multiple sclerosis	0.00023	0.00286	CcSEcCtD
Magnesium salicylate—Pain—Prednisolone—multiple sclerosis	0.000229	0.00285	CcSEcCtD
Magnesium salicylate—Hepatitis—Methotrexate—multiple sclerosis	0.000229	0.00285	CcSEcCtD
Magnesium salicylate—Oedema—Dexamethasone—multiple sclerosis	0.000224	0.00278	CcSEcCtD
Magnesium salicylate—Oedema—Betamethasone—multiple sclerosis	0.000224	0.00278	CcSEcCtD
Magnesium salicylate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000224	0.00278	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000221	0.00275	CcSEcCtD
Magnesium salicylate—Shock—Betamethasone—multiple sclerosis	0.00022	0.00274	CcSEcCtD
Magnesium salicylate—Shock—Dexamethasone—multiple sclerosis	0.00022	0.00274	CcSEcCtD
Magnesium salicylate—Dyspepsia—Triamcinolone—multiple sclerosis	0.000217	0.0027	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Methotrexate—multiple sclerosis	0.000217	0.00269	CcSEcCtD
Magnesium salicylate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000217	0.00269	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000216	0.00269	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000216	0.00269	CcSEcCtD
Magnesium salicylate—Tinnitus—Methotrexate—multiple sclerosis	0.000214	0.00266	CcSEcCtD
Magnesium salicylate—Anorexia—Dexamethasone—multiple sclerosis	0.000213	0.00265	CcSEcCtD
Magnesium salicylate—Anorexia—Betamethasone—multiple sclerosis	0.000213	0.00265	CcSEcCtD
Magnesium salicylate—Urticaria—Prednisolone—multiple sclerosis	0.000213	0.00265	CcSEcCtD
Magnesium salicylate—Ketoprofen—ALB—multiple sclerosis	0.000212	0.0578	CrCbGaD
Magnesium salicylate—Pain—Triamcinolone—multiple sclerosis	0.000211	0.00262	CcSEcCtD
Magnesium salicylate—Hypotension—Betamethasone—multiple sclerosis	0.000209	0.0026	CcSEcCtD
Magnesium salicylate—Hypotension—Dexamethasone—multiple sclerosis	0.000209	0.0026	CcSEcCtD
Magnesium salicylate—Vomiting—Mitoxantrone—multiple sclerosis	0.000208	0.00258	CcSEcCtD
Magnesium salicylate—Rash—Mitoxantrone—multiple sclerosis	0.000206	0.00256	CcSEcCtD
Magnesium salicylate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000206	0.00256	CcSEcCtD
Magnesium salicylate—Headache—Mitoxantrone—multiple sclerosis	0.000205	0.00254	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000203	0.00253	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000203	0.00252	CcSEcCtD
Magnesium salicylate—Erythema—Methotrexate—multiple sclerosis	0.0002	0.00248	CcSEcCtD
Magnesium salicylate—Dyspepsia—Betamethasone—multiple sclerosis	0.000197	0.00245	CcSEcCtD
Magnesium salicylate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000197	0.00245	CcSEcCtD
Magnesium salicylate—Urticaria—Triamcinolone—multiple sclerosis	0.000196	0.00243	CcSEcCtD
Magnesium salicylate—Urticaria—Methylprednisolone—multiple sclerosis	0.000196	0.00243	CcSEcCtD
Magnesium salicylate—Dysgeusia—Methotrexate—multiple sclerosis	0.000195	0.00243	CcSEcCtD
Magnesium salicylate—Oedema—Prednisone—multiple sclerosis	0.000195	0.00242	CcSEcCtD
Magnesium salicylate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000195	0.00242	CcSEcCtD
Magnesium salicylate—Decreased appetite—Betamethasone—multiple sclerosis	0.000195	0.00242	CcSEcCtD
Magnesium salicylate—Nausea—Mitoxantrone—multiple sclerosis	0.000194	0.00241	CcSEcCtD
Magnesium salicylate—Shock—Prednisone—multiple sclerosis	0.000192	0.00238	CcSEcCtD
Magnesium salicylate—Pain—Dexamethasone—multiple sclerosis	0.000191	0.00238	CcSEcCtD
Magnesium salicylate—Pain—Betamethasone—multiple sclerosis	0.000191	0.00238	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000188	0.00234	CcSEcCtD
Magnesium salicylate—Anorexia—Prednisone—multiple sclerosis	0.000186	0.00231	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000184	0.00229	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000184	0.00229	CcSEcCtD
Magnesium salicylate—Urticaria—Dexamethasone—multiple sclerosis	0.000178	0.00221	CcSEcCtD
Magnesium salicylate—Urticaria—Betamethasone—multiple sclerosis	0.000178	0.00221	CcSEcCtD
Magnesium salicylate—Dizziness—Prednisolone—multiple sclerosis	0.000177	0.0022	CcSEcCtD
Magnesium salicylate—Pruritus—Triamcinolone—multiple sclerosis	0.000175	0.00217	CcSEcCtD
Magnesium salicylate—Pruritus—Methylprednisolone—multiple sclerosis	0.000174	0.00216	CcSEcCtD
Magnesium salicylate—Dyspepsia—Prednisone—multiple sclerosis	0.000172	0.00213	CcSEcCtD
Magnesium salicylate—Decreased appetite—Prednisone—multiple sclerosis	0.000169	0.00211	CcSEcCtD
Magnesium salicylate—Rash—Prednisolone—multiple sclerosis	0.000169	0.0021	CcSEcCtD
Magnesium salicylate—Dermatitis—Prednisolone—multiple sclerosis	0.000169	0.0021	CcSEcCtD
Magnesium salicylate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000168	0.00209	CcSEcCtD
Magnesium salicylate—Headache—Prednisolone—multiple sclerosis	0.000168	0.00209	CcSEcCtD
Magnesium salicylate—Constipation—Prednisone—multiple sclerosis	0.000167	0.00207	CcSEcCtD
Magnesium salicylate—Confusional state—Methotrexate—multiple sclerosis	0.000164	0.00204	CcSEcCtD
Magnesium salicylate—Dizziness—Triamcinolone—multiple sclerosis	0.000163	0.00203	CcSEcCtD
Magnesium salicylate—Dizziness—Methylprednisolone—multiple sclerosis	0.000163	0.00202	CcSEcCtD
Magnesium salicylate—PTGS2—S1P1 pathway—S1PR1—multiple sclerosis	0.000161	0.0646	CbGpPWpGaD
Magnesium salicylate—Feeling abnormal—Prednisone—multiple sclerosis	0.000161	0.002	CcSEcCtD
Magnesium salicylate—Nausea—Prednisolone—multiple sclerosis	0.000159	0.00198	CcSEcCtD
Magnesium salicylate—Pruritus—Betamethasone—multiple sclerosis	0.000158	0.00197	CcSEcCtD
Magnesium salicylate—Pruritus—Dexamethasone—multiple sclerosis	0.000158	0.00197	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000157	0.00196	CcSEcCtD
Magnesium salicylate—Vomiting—Triamcinolone—multiple sclerosis	0.000157	0.00195	CcSEcCtD
Magnesium salicylate—Vomiting—Methylprednisolone—multiple sclerosis	0.000156	0.00194	CcSEcCtD
Magnesium salicylate—Rash—Triamcinolone—multiple sclerosis	0.000156	0.00193	CcSEcCtD
Magnesium salicylate—Dermatitis—Triamcinolone—multiple sclerosis	0.000155	0.00193	CcSEcCtD
Magnesium salicylate—Anorexia—Methotrexate—multiple sclerosis	0.000155	0.00193	CcSEcCtD
Magnesium salicylate—Rash—Methylprednisolone—multiple sclerosis	0.000155	0.00193	CcSEcCtD
Magnesium salicylate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000155	0.00193	CcSEcCtD
Magnesium salicylate—Urticaria—Prednisone—multiple sclerosis	0.000155	0.00192	CcSEcCtD
Magnesium salicylate—Headache—Triamcinolone—multiple sclerosis	0.000155	0.00192	CcSEcCtD
Magnesium salicylate—Headache—Methylprednisolone—multiple sclerosis	0.000154	0.00192	CcSEcCtD
Magnesium salicylate—Diarrhoea—Betamethasone—multiple sclerosis	0.000153	0.0019	CcSEcCtD
Magnesium salicylate—Diarrhoea—Dexamethasone—multiple sclerosis	0.000153	0.0019	CcSEcCtD
Magnesium salicylate—Hypotension—Methotrexate—multiple sclerosis	0.000152	0.00189	CcSEcCtD
Magnesium salicylate—Dizziness—Betamethasone—multiple sclerosis	0.000148	0.00184	CcSEcCtD
Magnesium salicylate—Dizziness—Dexamethasone—multiple sclerosis	0.000148	0.00184	CcSEcCtD
Magnesium salicylate—Nausea—Triamcinolone—multiple sclerosis	0.000147	0.00182	CcSEcCtD
Magnesium salicylate—Nausea—Methylprednisolone—multiple sclerosis	0.000146	0.00182	CcSEcCtD
Magnesium salicylate—Somnolence—Methotrexate—multiple sclerosis	0.000145	0.0018	CcSEcCtD
Magnesium salicylate—Dyspepsia—Methotrexate—multiple sclerosis	0.000143	0.00178	CcSEcCtD
Magnesium salicylate—Vomiting—Betamethasone—multiple sclerosis	0.000142	0.00177	CcSEcCtD
Magnesium salicylate—Vomiting—Dexamethasone—multiple sclerosis	0.000142	0.00177	CcSEcCtD
Magnesium salicylate—Decreased appetite—Methotrexate—multiple sclerosis	0.000142	0.00176	CcSEcCtD
Magnesium salicylate—Rash—Betamethasone—multiple sclerosis	0.000141	0.00175	CcSEcCtD
Magnesium salicylate—Rash—Dexamethasone—multiple sclerosis	0.000141	0.00175	CcSEcCtD
Magnesium salicylate—Dermatitis—Dexamethasone—multiple sclerosis	0.000141	0.00175	CcSEcCtD
Magnesium salicylate—Dermatitis—Betamethasone—multiple sclerosis	0.000141	0.00175	CcSEcCtD
Magnesium salicylate—Headache—Betamethasone—multiple sclerosis	0.00014	0.00174	CcSEcCtD
Magnesium salicylate—Headache—Dexamethasone—multiple sclerosis	0.00014	0.00174	CcSEcCtD
Magnesium salicylate—Pain—Methotrexate—multiple sclerosis	0.000139	0.00173	CcSEcCtD
Magnesium salicylate—Pruritus—Prednisone—multiple sclerosis	0.000138	0.00171	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000134	0.00167	CcSEcCtD
Magnesium salicylate—Diarrhoea—Prednisone—multiple sclerosis	0.000133	0.00166	CcSEcCtD
Magnesium salicylate—Nausea—Betamethasone—multiple sclerosis	0.000133	0.00165	CcSEcCtD
Magnesium salicylate—Nausea—Dexamethasone—multiple sclerosis	0.000133	0.00165	CcSEcCtD
Magnesium salicylate—Urticaria—Methotrexate—multiple sclerosis	0.000129	0.00161	CcSEcCtD
Magnesium salicylate—Dizziness—Prednisone—multiple sclerosis	0.000129	0.0016	CcSEcCtD
Magnesium salicylate—Vomiting—Prednisone—multiple sclerosis	0.000124	0.00154	CcSEcCtD
Magnesium salicylate—Rash—Prednisone—multiple sclerosis	0.000123	0.00153	CcSEcCtD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTPRK—multiple sclerosis	0.000123	0.0492	CbGpPWpGaD
Magnesium salicylate—Dermatitis—Prednisone—multiple sclerosis	0.000123	0.00153	CcSEcCtD
Magnesium salicylate—Headache—Prednisone—multiple sclerosis	0.000122	0.00152	CcSEcCtD
Magnesium salicylate—Nausea—Prednisone—multiple sclerosis	0.000116	0.00144	CcSEcCtD
Magnesium salicylate—Pruritus—Methotrexate—multiple sclerosis	0.000115	0.00143	CcSEcCtD
Magnesium salicylate—Diarrhoea—Methotrexate—multiple sclerosis	0.000111	0.00138	CcSEcCtD
Magnesium salicylate—Dizziness—Methotrexate—multiple sclerosis	0.000108	0.00134	CcSEcCtD
Magnesium salicylate—Vomiting—Methotrexate—multiple sclerosis	0.000104	0.00129	CcSEcCtD
Magnesium salicylate—Rash—Methotrexate—multiple sclerosis	0.000103	0.00128	CcSEcCtD
Magnesium salicylate—Dermatitis—Methotrexate—multiple sclerosis	0.000103	0.00127	CcSEcCtD
Magnesium salicylate—Headache—Methotrexate—multiple sclerosis	0.000102	0.00127	CcSEcCtD
Magnesium salicylate—Nausea—Methotrexate—multiple sclerosis	9.67e-05	0.0012	CcSEcCtD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TBX21—multiple sclerosis	7.92e-05	0.0317	CbGpPWpGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	7.13e-05	0.0286	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.99e-05	0.028	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.99e-05	0.028	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CBLB—multiple sclerosis	5.81e-05	0.0233	CbGpPWpGaD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—PTGER4—multiple sclerosis	5.66e-05	0.0227	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—multiple sclerosis	4.71e-05	0.0189	CbGpPWpGaD
Magnesium salicylate—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	4.39e-05	0.0176	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—multiple sclerosis	3.9e-05	0.0156	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—multiple sclerosis	3.79e-05	0.0152	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP24A1—multiple sclerosis	3.71e-05	0.0149	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP27B1—multiple sclerosis	3.71e-05	0.0149	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—PLEK—multiple sclerosis	3.58e-05	0.0144	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2RA—multiple sclerosis	3.47e-05	0.0139	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	3.42e-05	0.0137	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MBP—multiple sclerosis	3.39e-05	0.0136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CTLA4—multiple sclerosis	3.24e-05	0.013	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—TNF—multiple sclerosis	2.62e-05	0.0105	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—AQP4—multiple sclerosis	2.57e-05	0.0103	CbGpPWpGaD
Magnesium salicylate—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	2.52e-05	0.0101	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—multiple sclerosis	2.52e-05	0.0101	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—multiple sclerosis	2.45e-05	0.00982	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—multiple sclerosis	2.29e-05	0.00917	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—multiple sclerosis	2.25e-05	0.00899	CbGpPWpGaD
Magnesium salicylate—PTGS2—S1P1 pathway—MAPK1—multiple sclerosis	2.18e-05	0.00875	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—IL6—multiple sclerosis	2.11e-05	0.00847	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—TNF—multiple sclerosis	2.08e-05	0.00833	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	2.05e-05	0.00822	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—multiple sclerosis	2.04e-05	0.00815	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	2.01e-05	0.00807	CbGpPWpGaD
Magnesium salicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	1.97e-05	0.00787	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	1.84e-05	0.00738	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CCR2—multiple sclerosis	1.78e-05	0.00712	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—IL6—multiple sclerosis	1.68e-05	0.00672	CbGpPWpGaD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	1.68e-05	0.00672	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	1.65e-05	0.00661	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	1.59e-05	0.00637	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL4—multiple sclerosis	1.59e-05	0.00636	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.57e-05	0.00629	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1.56e-05	0.00625	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	1.55e-05	0.00621	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—multiple sclerosis	1.48e-05	0.00593	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CXCL10—multiple sclerosis	1.48e-05	0.00592	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.43e-05	0.00571	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.43e-05	0.00571	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.4e-05	0.00559	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	1.4e-05	0.00559	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	1.39e-05	0.00556	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—BDNF—multiple sclerosis	1.33e-05	0.00532	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SELPLG—multiple sclerosis	1.33e-05	0.00531	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CD58—multiple sclerosis	1.33e-05	0.00531	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MERTK—multiple sclerosis	1.33e-05	0.00531	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—multiple sclerosis	1.32e-05	0.00527	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—ALB—multiple sclerosis	1.3e-05	0.00521	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—ICAM1—multiple sclerosis	1.26e-05	0.00505	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1.24e-05	0.00496	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL4—multiple sclerosis	1.23e-05	0.00494	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IFNG—multiple sclerosis	1.19e-05	0.00476	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	1.18e-05	0.00473	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.13e-05	0.00453	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.13e-05	0.00453	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—CCL2—multiple sclerosis	1.13e-05	0.00452	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.13e-05	0.00451	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—CCL2—multiple sclerosis	1.11e-05	0.00444	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	1.1e-05	0.00441	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	1.08e-05	0.00431	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IL1B—multiple sclerosis	1.06e-05	0.00424	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	1.05e-05	0.00421	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—ALB—multiple sclerosis	1.03e-05	0.00414	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	1.03e-05	0.00411	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TLR4—multiple sclerosis	1.02e-05	0.00409	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	1e-05	0.00401	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—ICAM1—multiple sclerosis	9.8e-06	0.00392	CbGpPWpGaD
Magnesium salicylate—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.76e-06	0.00391	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IFNG—multiple sclerosis	9.6e-06	0.00384	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—multiple sclerosis	9.59e-06	0.00384	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—CD4—multiple sclerosis	9.45e-06	0.00378	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IFNG—multiple sclerosis	9.43e-06	0.00377	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	9.36e-06	0.00375	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	9.15e-06	0.00367	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	9.15e-06	0.00367	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	9.03e-06	0.00362	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—SRM—multiple sclerosis	9.01e-06	0.00361	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	8.97e-06	0.00359	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—CCL2—multiple sclerosis	8.77e-06	0.00351	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL1B—multiple sclerosis	8.56e-06	0.00343	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL2—multiple sclerosis	8.53e-06	0.00342	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL1B—multiple sclerosis	8.41e-06	0.00337	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—POMC—multiple sclerosis	8.35e-06	0.00334	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLEK—multiple sclerosis	8.2e-06	0.00328	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.73e-06	0.0031	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—TNF—multiple sclerosis	7.68e-06	0.00308	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	7.64e-06	0.00306	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	7.63e-06	0.00305	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IFNG—multiple sclerosis	7.45e-06	0.00299	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—SRM—multiple sclerosis	7.15e-06	0.00286	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.1e-06	0.00284	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	6.8e-06	0.00272	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MYC—multiple sclerosis	6.8e-06	0.00272	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL1B—multiple sclerosis	6.65e-06	0.00266	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL2—multiple sclerosis	6.62e-06	0.00265	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP27B1—multiple sclerosis	6.35e-06	0.00254	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP24A1—multiple sclerosis	6.35e-06	0.00254	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MMP9—multiple sclerosis	6.27e-06	0.00251	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—multiple sclerosis	6.21e-06	0.00249	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.2e-06	0.00248	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IL6—multiple sclerosis	6.2e-06	0.00248	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	6.16e-06	0.00247	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—multiple sclerosis	6.1e-06	0.00244	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GPC5—multiple sclerosis	5.81e-06	0.00232	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—SRM—multiple sclerosis	5.79e-06	0.00232	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—SELE—multiple sclerosis	5.77e-06	0.00231	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—TGFB1—multiple sclerosis	5.7e-06	0.00228	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.61e-06	0.00225	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	5.53e-06	0.00222	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GPC5—multiple sclerosis	5.5e-06	0.0022	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	5.43e-06	0.00218	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MYC—multiple sclerosis	5.18e-06	0.00207	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TGFB1—multiple sclerosis	5.17e-06	0.00207	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MAPK1—multiple sclerosis	5.07e-06	0.00203	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP27B1—multiple sclerosis	5.04e-06	0.00202	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP24A1—multiple sclerosis	5.04e-06	0.00202	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL6—multiple sclerosis	5.01e-06	0.00201	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.96e-06	0.00199	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	4.94e-06	0.00198	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.92e-06	0.00197	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL6—multiple sclerosis	4.92e-06	0.00197	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—multiple sclerosis	4.82e-06	0.00193	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—RRM1—multiple sclerosis	4.81e-06	0.00193	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GPC5—multiple sclerosis	4.61e-06	0.00185	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ITGA4—multiple sclerosis	4.18e-06	0.00167	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IFNB1—multiple sclerosis	4.14e-06	0.00166	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP24A1—multiple sclerosis	4.08e-06	0.00163	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP27B1—multiple sclerosis	4.08e-06	0.00163	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	3.98e-06	0.0016	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	3.98e-06	0.0016	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL6—multiple sclerosis	3.89e-06	0.00156	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—RRM1—multiple sclerosis	3.82e-06	0.00153	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.73e-06	0.00149	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GPC5—multiple sclerosis	3.73e-06	0.00149	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RPL5—multiple sclerosis	3.58e-06	0.00143	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.52e-06	0.00141	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.51e-06	0.00141	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.45e-06	0.00138	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SLC11A1—multiple sclerosis	3.43e-06	0.00137	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.28e-06	0.00131	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	3.24e-06	0.0013	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.21e-06	0.00128	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—RRM1—multiple sclerosis	3.09e-06	0.00124	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.96e-06	0.00119	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.92e-06	0.00117	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2RA—multiple sclerosis	2.85e-06	0.00114	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—BCHE—multiple sclerosis	2.76e-06	0.00111	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD28—multiple sclerosis	2.74e-06	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.55e-06	0.00102	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	2.53e-06	0.00101	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	2.48e-06	0.000994	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.4e-06	0.00096	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.32e-06	0.000929	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—BCHE—multiple sclerosis	2.19e-06	0.000878	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.06e-06	0.000825	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD86—multiple sclerosis	1.95e-06	0.000782	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—BCHE—multiple sclerosis	1.77e-06	0.000711	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CCR5—multiple sclerosis	1.73e-06	0.000694	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—HLA-A—multiple sclerosis	1.69e-06	0.000676	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IL2—multiple sclerosis	1.67e-06	0.00067	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—APOE—multiple sclerosis	1.66e-06	0.000666	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—APOE—multiple sclerosis	1.58e-06	0.000631	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—POMC—multiple sclerosis	1.43e-06	0.000572	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD80—multiple sclerosis	1.42e-06	0.00057	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—APOE—multiple sclerosis	1.32e-06	0.000528	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB1—multiple sclerosis	1.3e-06	0.000522	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ALB—multiple sclerosis	1.3e-06	0.000521	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MAPK1—multiple sclerosis	1.28e-06	0.000512	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TYK2—multiple sclerosis	1.2e-06	0.000482	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—POMC—multiple sclerosis	1.13e-06	0.000454	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CD4—multiple sclerosis	1.09e-06	0.000436	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—APOE—multiple sclerosis	1.07e-06	0.000428	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ALB—multiple sclerosis	1.03e-06	0.000414	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—POMC—multiple sclerosis	9.17e-07	0.000367	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—STAT3—multiple sclerosis	8.42e-07	0.000337	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—multiple sclerosis	7.82e-07	0.000313	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFB1—multiple sclerosis	7.8e-07	0.000313	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MAPK1—multiple sclerosis	7.65e-07	0.000307	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6—multiple sclerosis	5.88e-07	0.000236	CbGpPWpGaD
